These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 1773831)

  • 1. Antioxidant effect of calcium antagonists on microsomal membranes isolated from different brain areas.
    Gonçalves T; Carvalho AP; Oliveira CR
    Eur J Pharmacol; 1991 Nov; 204(3):315-22. PubMed ID: 1773831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protection of cardiac membrane phospholipid against oxidative injury by calcium antagonists.
    Janero DR; Burghardt B; Lopez R
    Biochem Pharmacol; 1988 Nov; 37(21):4197-203. PubMed ID: 3190757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antioxidant properties of calcium antagonists related to membrane biophysical interactions.
    Mason RP; Mak IT; Trumbore MW; Mason PE
    Am J Cardiol; 1999 Aug; 84(4A):16L-22L. PubMed ID: 10480441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative antioxidant effects of beta-adrenoceptor blockers, calcium antagonists and U-74500A against iron-dependent lipid peroxidation in murine ventricular microsomal membranes.
    Reddy DS; Singh M; Chopra K
    Methods Find Exp Clin Pharmacol; 1996 Nov; 18(9):559-67. PubMed ID: 9010829
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antioxidant effects of calcium antagonists on rat myocardial membrane lipid peroxidation.
    Sugawara H; Tobise K; Kikuchi K
    Hypertens Res; 1996 Dec; 19(4):223-8. PubMed ID: 8986452
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Partitioning and membrane disordering effects of dopamine antagonists: influence of lipid peroxidation, temperature, and drug concentration.
    Palmeira CM; Oliveira CR
    Arch Biochem Biophys; 1992 May; 295(1):161-71. PubMed ID: 1575512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of Na+-Ca2+ exchange by calcium antagonists in rat brain microsomal membranes.
    Ruscák M; Juhász O; Orlický J; Zachar J
    Gen Physiol Biophys; 1986 Oct; 5(5):529-35. PubMed ID: 2433186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Attenuation of daunorubicin-augmented microsomal lipid peroxidation and oxygen consumption by calcium channel antagonists.
    Engineer FN; Sridhar R
    Biochem Biophys Res Commun; 1991 Sep; 179(2):1101-6. PubMed ID: 1654899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antioxidant effects of calcium antagonists in rat brain homogenates.
    Yao K; Ina Y; Nagashima K; Ohmori K; Ohno T
    Biol Pharm Bull; 2000 Jun; 23(6):766-9. PubMed ID: 10864033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antioxidant effects of 1,4-dihydropyridine and nitroso aryl derivatives on the Fe+3/ascorbate-stimulated lipid peroxidation in rat brain slices.
    Díaz-Araya G; Godoy L; Naranjo L; Squella JA; Letelier ME; Núñez-Vergara LJ
    Gen Pharmacol; 1998 Sep; 31(3):385-91. PubMed ID: 9703206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of lipid peroxidation by dihydroquinoline-type antioxidant (CH 402).
    Blázovics A; Somogyi A; Lengyel G; Láng I; Fehér J
    Free Radic Res Commun; 1988; 4(6):409-13. PubMed ID: 3243505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of multiple administration of calcium antagonists on lipid peroxidation in rat liver microsomes.
    Koleva M; Alov P
    Gen Pharmacol; 1996 Jul; 27(5):891-3. PubMed ID: 8842695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Partition of Ca2+ antagonists in brain plasma membranes.
    Carvalho CM; Oliveira CR; Lima MP; Leysen JE; Carvalho AP
    Biochem Pharmacol; 1989 Jul; 38(13):2121-7. PubMed ID: 2735950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antioxidant properties and membranotropic effect of certain derivatives of 1,4-dihydropyridine].
    Gubskiĭ IuI; Goriushko AG; Litvinova NV; Pirmak RG; Kruskaia NM; Shnurko EV; Sachenko LG
    Ukr Biokhim Zh (1999); 1999; 71(4):35-9. PubMed ID: 10791054
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antioxidant and antiradical activity of various classes of antioxidants].
    Gubskiĭ IuI; Litvinova NV; Shnurko-Tabakova EV
    Ukr Biokhim Zh (1978); 1994; 66(4):114-7. PubMed ID: 7879283
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Calcium channel blockers inhibit the (Ca2+ + Mg2+)-ATPase activity and the 125I-calmodulin binding in brain membranes.
    Santos DL; Lopes MC; Carvalho CM
    Eur J Pharmacol; 1994 May; 267(3):307-16. PubMed ID: 8088369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection by Ca2+ channel blockers (nifedipine, diltiazem and verapamil) against the toxicity of oxidized low density lipoprotein to cultured lymphoid cells.
    Nègre-Salvayre A; Salvayre R
    Br J Pharmacol; 1992 Nov; 107(3):738-44. PubMed ID: 1472971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uteroferrin induces lipid peroxidation in endometrial and conceptus microsomal membranes and is inhibited by apotransferrin, retinol binding protein, and the uteroferrin-associated proteins.
    Vallet JL
    Biol Reprod; 1995 Dec; 53(6):1436-45. PubMed ID: 8562701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of LDL oxidation and oxidized LDL-induced cytotoxicity by dihydropyridine calcium antagonists.
    Sevanian A; Shen L; Ursini F
    Pharm Res; 2000 Aug; 17(8):999-1006. PubMed ID: 11028948
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Free radical scavenging and inhibition of lipid peroxidation by beta-blockers and by agents that interfere with calcium metabolism. A physiologically-significant process?
    Aruoma OI; Smith C; Cecchini R; Evans PJ; Halliwell B
    Biochem Pharmacol; 1991 Jul; 42(4):735-43. PubMed ID: 1678258
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.